Abstract
Pain perception and threshold show complex interactions with the inflammatory, psychiatric and neuroendocrine stimuli. This study aims to test whether lower serum cortisol levels are associated with lower pain thresholds and higher degree of depression in systemic sclerosis (SSc) and major depression with atypical features (MD-AF) patients compared to controls. 180 female subjects (SSc = 60, MD-AF = 60, healthy controls = 60) participated in this observational, cross-sectional, parallel group study. Pressure pain threshold (PPT) was assessed in three anatomical sites: nail bed (NB), metacarpophalangeal joint (MCP) and quadriceps muscle (QDR). Depressive symptoms were evaluated using the Beck Depression Inventory (BDI) scale and morning serum cortisol levels were collected. In SSc patients, quality of life was measured through the Health Assessment Questionnaire (HAQ-DI) and the scleroderma-specific visual analogue scales (scleroderma-VAS). Lower PPT scores (NB 4.42 ± 1.6; MCP 4.66 ± 1.4; QDR 4.79 ± 1.5) were observed in SSc patients compared to both MD-AF (NB 7.33 ± 2.2; MCP 6.01 ± 1.9; QDR 6.31 ± 1.6; p < 0.005) and controls (NB 9.57 ± 2; MCP 7.9 ± 2.1 and QDR 8.43 ± 2.1; p < 0.0001), while MD-AF patients had lower PPT scores compared to controls (p < 0.0001). SSc patients had also lower serum cortisol levels compared to MD-AF patients (8.78 vs 13.6 μg/dl; p < 0.05). A direct correlation was observed between serum cortisol and PPT scores both in SSc (r 2 for NB 0.29; for MCP 0.25; for QDR 0.27) and in MD-AF (r 2 for NB 0.34; for MCP 0.25; for QDR 0.47; p < 0.05), while depressive symptoms negatively correlated with serum cortisol (r 2 for NB 0.34; for MCP 0.17; for QDR 0.15) and in MD-AF (r 2 for NB 0.19; for MCP 0.31; for QDR 0.30; p < 0.05). Among SSc patients, those with serum cortisol levels below the normal range (n = 16) had higher BDI scores (15, 6–21 vs 9, 2–15; p < 0.005), lower PPTs (NB 4 ± 1.4 vs 4.9 ± 0.9; MCP 4.1 ± 0.8 vs 4.8 ± 0.9; QDR 4.1 ± 1.2 vs 5 ± 0.9; p < 0.005) and higher HAQ-DI (1.25, 0.25–2 vs 0.75, 0–1.25; p < 0.05) and scleroderma-VAS scores (VAS overall severity 7, 5.5–9.5 vs 4.5, 2.5–6; p < 0.05). The effect of cortisol serum levels upon pain mechanism, in chronic inflammatory conditions warrants longitudinal studies to detect treatable variations in pain thresholds, depressive symptoms and to improve quality of life.
Similar content being viewed by others
References
Almeida C, Almeida I, Vasconcelos C (2015) Quality of life in systemic sclerosis. Autoimmun Rev 14:1087–1096
Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M (2009) Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheumatol 61:1112–1120
Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O et al (2006) Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatol (Oxf) 45:1298–1302
Thombs BD, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA (2008) A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples. Rheumatol (Oxf) 47:1559–1563
Nguyen C, Ranque B, Baubet T, Bérezné A, Mestre-Stanislas C, Rannou F et al (2014) Groupe Français de Recherche sur la Sclérodermie. Clinical, functional and health-related quality of life correlates of clinically significant symptoms of anxiety and depression in patients with systemic sclerosis: a cross-sectional survey. PLoS One 28(9):e904849
Mura G, Bhat KM, Pisano A, Licci G, Carta M (2012) Psychiatric symptoms and quality of life in systemic sclerosis. Clin Pract Epidemiol Ment Health 8:30–35
Aloisi AM (2003) Gonadal hormones and sex differences in pain reactivity. Clin J Pain 19:168–174
McEwen BS, Kalia M (2010) The role of corticosteroids and stress in chronic pain conditions. Metabolism 59:S9–S15
Muhtz C, Rodriguez-Raecke R, Hinkelmann K, Moeller-Bertram T, Kiefer F, Wiedemann K et al (2013) Cortisol response to experimental pain in patients with chronic low back pain and patients with major depression. Pain Med 14:498–503
Spies CM, Straub RH, Cutolo M, Buttgereit F (2014) Circadian rhythms in rheumatology—a glucocorticoid perspective. Arthritis Res Ther 13(16 Suppl 2):S3
Addington JW (2000) Chronic fatigue syndrome: a dysfunction of the hypothalamic-pituitary-adrenal axis. J Chronic Fatigue Syndr 7:63–73
Gur A, Cevik R, Nas K, Colpan L, Sarac S (2004) Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 6:R232–R238
Tak LM, Rosmalen JG (2010) Dysfunction of stress responsive systems as a risk factor for functional somatic syndromes. J Psychosom Res 68:461–468
Gold PW (2015) The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry 20:32–47
O’Keane V, Frodl T, Dinan TG (2012) A review of atypical depression in relation to the course of depression and changes in HPA axis organization. Psychoneuroendocrinology 37:1589–1599
Singh T, Williams K (2006) Atypical depression. Psychiatry (Edgmont) 3:33–39
Anisman H, Ravindran AV, Griffiths J, Merali Z (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182–188
Karlović D, Serretti A, Vrkić N, Martinac M, Marčinko D (2012) Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res 198:74–80
Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C et al (2005) Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol 152:185–191
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheumatol Dis 72:1747–1755
Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285
Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34:1184–1186
Lee YC, Chibnik LB, Lu B, Wasan AD, Edwards RR, Fossel AH et al (2009) The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 11:R160
Walton DM, Macdermid JC, Nielson W, Teasell RW, Chiasson M, Brown L (2011) Reliability, standard error, and minimum detectable change of clinical pressure pain threshold testing in people with and without acute neck pain. J Orthop Sports Phys Ther 41:644–650
Lee YC, Lu B, Edwards RR, Wasan AD, Nassikas NJ, Clauw DJ et al. (2013) The role of sleep problems in central pain processing in rheumatoid arthritis. Arthritis Rheumatol 65:59–68
Wajed J, Ejindu V, Heron C, Hermansson M, Kiely P, Sofat N (2012) Quantitative sensory testing in painful hand osteoarthritis demonstrates features of peripheral sensitisation. Int J Rheumatol 2012:703138
Pope J (2011) Measures of systemic sclerosis scleroderma: Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler’s Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud’s Condition Score (RCS). Arthritis Care Res (Hoboken) 63:S98–S111
Normand E, Potvin S, Gaumond I, Cloutier G, Corbin JF, Marchand S (2011) Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. J Clin Psychiatry 72:219–224
Zambito Marsala S, Pistacchi M, Tocco P, Gioulis M, Fabris F, Brigo F et al (2015) Pain perception in major depressive disorder: a neurophysiological case–control study. J Neurol Sci 357:19–21
Lautenbacher S, Spernal J, Schreiber W, Krieg JC (1999) Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61:822–827
Boettger MK, Grossmann D, Bär KJ (2013) Thresholds and perception of cold pain, heat pain, and the thermal grill illusion in patients with major depressive disorder. Psychosom Med 75:281–287
Euteneuer F, Schwarz MJ, Hennings A, Riemer S, Stapf T, Selberdinger V et al (2011) Depression, cytokines and experimental pain: evidence for sex-related association patterns. J Affect Disord 131:143–149
Neogi T, Guermazi A, Roemer F, Nevitt MC, Scholz J, Arendt-Nielsen L et al (2016) Association of joint inflammation with pain sensitization in knee osteoarthritis: the Multicenter Osteoarthritis Study. Arthritis Rheumatol 68:654–661
Silverman MN, Sternberg EM (2012) Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261:55–63
Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477–501
Pace TW, Miller AH (2009) Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann N Y Acad Sci 1179:86–105
Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002) Hypothalamic–pituitary–adrenal axis function in patients with chronic depression. Psychol Med 32:1021–1028
McEwen BS, Kalia M (2010) The role of corticosteroids and stress in chronic pain conditions. Metabolism 59:S9–S15
Paananen M, O’Sullivan P, Straker L, Beales D, Coenen P, Karppinen J et al (2015) A low cortisol response to stress is associated with musculoskeletal pain combined with increased pain sensitivity in young adults: a longitudinal cohort study. Arthritis Res Ther 10:355
Kuehl LK, Michaux GP, Richter S, Schächinger H, Anton F (2010) Increased basal mechanical pain sensitivity but decreased perceptual wind-up in a human model of relative hypocortisolism. Pain 149:539–546
Steen VD, Medsger TA Jr (1998) Case–control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheumatol 41:1613–1619
Author information
Authors and Affiliations
Contributions
All authors were involved in drafting the article and revising it critically for important intellectual content, and all authors approved the final version to be published. Study concept and design: GLB, FC, WNR, AB, MRAM. Acquisition of data: DSC, DSA, MRAM, AF, GM, GC. Analysis and interpretation of data: GLB, FC, GP, RZ, WNR, AB.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Bagnato, G., Cordova, F., Sciortino, D. et al. Association between cortisol levels and pain threshold in systemic sclerosis and major depression. Rheumatol Int 38, 433–441 (2018). https://doi.org/10.1007/s00296-017-3866-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3866-3